Genetic Research Instruments for Newborn Screening

Definitive insights to shape healthier futures

TaqMan SCID/SMA Plus assay and TaqMan SCID/SMA assay require a qPCR instrument with at least 5 filters and are compatible with a wide range of QuantStudio instruments.  QuantStudio Real-Time PCR systems detect changes in gene expressions as low as 1.5-fold. The system supports a broad range of genomic applications, such as analyses of gene expression, microRNAs and noncoding RNAs, copy number variation, drug metabolism enzymes, and protein expression; SNP genotyping; and mutation detection.

Workflow

Thermo Fisher Scientific offers two robust assays for simultaneous detection of severe combined immunodeficiency syndrome (SCID) and spinal muscular atrophy (SMA) directly from dried blood spot (DBS) samples, empowering clinical researchers globally to make well educated decisions.  

 

Our complete newborn screening platform includes assays, fully kitted reagents, array processing qPCR instruments and data analysis software for simplified interpretation and reporting. These tools support laboratories to maximize operational time.

Product overview

QuantStudio 3 and 5 Real-Time PCR Systems

QuantStudio 6 and 7 Flex Real-Time PCR Systems

QuantStudio 12K Flex Real-Time PCR System

For Research Use Only. Not for use in diagnostic procedures.